Company Monitoring Page for Allergan

latest headlines for company on cafepharma

Allergen builds case for first drug therapy for presbyopia
Pharmaforum
Mon, 07/26/21 - 09:35 am
Tags:
Allergan, presbyopia, AGN-190584
Can Evolus Disrupt the Botox Market?
Motley Fool
Mon, 07/5/21 - 09:47 pm
Tags:
Evolus, Allergan, Jeuveau, Botox, aesthetics
AbbVie's Botox rolls out the red carpet for real people in new documentary-style ads
Fierce Pharma
Wed, 06/9/21 - 11:08 am
Tags:
Botox, Allergan, DTC advertising
AbbVie revives DTC ads for dry eye med Restasis with a patient front and center
Fierce Pharma
Mon, 04/26/21 - 10:48 am
Tags:
Allergan, Restasis, dry eye disease, DTC advertising, television ads
Johnson & Johnson, AbbVie, Teva and Endo to face pharma's first opioid trial since 2019
Fierce Pharma
Mon, 04/19/21 - 12:13 pm
Tags:
JNJ, AbbVie, Allergan, Teva Pharmaceutical, Endo, opioids, opioid crisis
AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report
Endpoints
Tue, 03/16/21 - 11:04 am
Tags:
AbbVie, Women's Health, Allergan, Humira, M&A
Lilly, Amgen and more back advocacy group's push to double migraine research dollars
Fierce Pharma
Tue, 01/5/21 - 10:52 pm
Tags:
Eli Lilly, Amgen, migraines, Allergan, Novartis, Biohaven, Teva Pharmaceutical
AbbVie dumps unwanted Sosei neuro pact from Allergan's past
Fierce Biotech
Tue, 01/5/21 - 10:17 am
Tags:
AbbVie, Allergan, M&A, Sosei
Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox
Biopharma Reporter
Tue, 12/22/20 - 10:51 am
Tags:
Aji Biopharma, ReVance, drug manufacturing, aesthetics, daxiabotulinumtoxinA, Botox, Allergan, AbbVie
AbbVie's Botox wins reprieve as agency bars Evolus' Jeaveau for alleged trade-secrets theft
Fierce Pharma
Thu, 12/17/20 - 06:26 pm
Tags:
AbbVie, Allergan, Botox, ITC, Evolus, Jeuveau
AbbVie chases its next golden goose for a post-Humira future with new ulcerative colitis data for Rinvoq
Endpoints
Wed, 12/9/20 - 10:39 am
Tags:
AbbVie, Allergan, Humira, Rinvoq
Unmet Need in Dry Eye Disease Market Leaves Room for Other Drugmakers to Step In
BioSpace
Fri, 11/13/20 - 12:49 pm
Tags:
dry eye disease, Novartis, Allergan, Sun Pharma, Bausch, Kala Pharmaceuticals
Former Allergan program posts positive topline PhIII results in farsightedness in an R&D win post-AbbVie merger
Endpoints
Wed, 10/28/20 - 10:50 am
Tags:
Allergan, AbbVie, presbyopia, clinical trials, AGN-190584
AbbVie’s Allergan Aesthetics brand gets a facelift
Fierce Pharma
Tue, 10/20/20 - 10:33 pm
Tags:
AbbVie, Allergan, aesthetics, branding
Its sale to Allergan was called off at the last minute. One year later, a biotech co-founded by Henri Termeer finds a new buyer
Endpoints
Thu, 10/1/20 - 10:01 am
Tags:
Lysosomal Therapeutics, Allergan, R&D, M&A, Henri Termeer, Bial
Vesper Healthcare Acquisition, a SPAC led by the former CEO of Allergan, files for a $400 million IPO
NASDAQ
Thu, 09/10/20 - 11:06 pm
Tags:
Vesper Healthcare Acquisition, Brent Saunders, Allergan, SPAC, IPOs
AbbVie & UroGen Overactive Bladder Treatment Misses in Phase 2 Trial
Xconomy
Thu, 08/27/20 - 10:22 pm
Tags:
AbbVie, Urogen, overactive bladder, Allergan, Botox
AbbVie cuts Editas CRISPR pact it inherited from Allergan
Fierce Biotech
Fri, 08/7/20 - 10:52 am
Tags:
Editas Medicine, Allergan, AbbVie, gene editing, CRISPR
AbbVie draws first blood in trade secrets war between Allergan's Botox and Evolus
Fierce Pharma
Wed, 07/8/20 - 11:52 pm
Tags:
AbbVie, Allergan, Evolus, Botox, Jeuveau, Daewoong Pharmaceuticals
FDA rejects AbbVie's eye drug, citing safety concerns
BioPharma Dive
Fri, 06/26/20 - 01:00 pm
Tags:
Allergan, AbbVie, FDA, abicipar, Molecular Partners, wet age-related macular degeneration

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.